Yeast model connects Alzheimer's disease risk and amyloid beta toxicity

In a development that sheds new light on the pathology of Alzheimer's disease (AD), a team of Whitehead Institute scientists has identified connections between genetic risk factors for the disease and the effects of a peptide toxic to nerve cells in the brains of AD patients.

Read the whole article on Physorg

More from Physorg